Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amisulpride in Chinese Patients With Schizophrenia
NCT01795183Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amisulpride in schizophrenia, sponsored by Sanofi. Started Nov 2012; status: completed.
02
Drugs
amisulpride
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01795183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01795183.